发明名称 Orally administrable composition capable of providing enhanced bioavailability when ingested
摘要 Composition for pharmaceutical or cosmetic use, capable of forming a microemulsion, comprising at least: an active principle, a lipophilic phase consisting of a mixture of fatty acid esters and glycerides, a surfactant (SA), a cosurfactant (CoSA), a hydrophilic phase, characterized: in that the lipophilic phase consists of a mixture of C8 to C18 polyglycolized glycerides having a hydrophilic-lipophilic balance (HLB) of less than 16, this lipophilic phase representing from 30 to 75% of the total weight of the composition; in that the surfactant (SA) is chosen from the group comprising saturated C8-C10 olyglycolized glycerides and oleic esters of polyglycerol, this surfactant having an HLB of less than 16; in that the cosurfactant (CoSA) is chosen from the group comprising lauric esters of propylene glycol, oleic esters of polyglycerol and ethyl diglycol; in that the SA/CoSA ratio is between 0.5 and 6; and in that the hydrophilic phase of the final microemulsion is supplied after ingestion by the physiological fluid of the digestive milieu.
申请公布号 US6054136(A) 申请公布日期 2000.04.25
申请号 US19970838893 申请日期 1997.04.11
申请人 GATTEFOSSE S.A. 发明人 FARAH, NABIL;DENIS, JOEL
分类号 A61K8/06;A61K8/39;A61K9/107;A61Q19/00;(IPC1-7):A61K9/00 主分类号 A61K8/06
代理机构 代理人
主权项
地址